Li Zhou

A Randomized, Open-label, Presurgical, Window-of-Opportunity Study Comparing the Pharmacodynamic Effects of the Novel Oral SERD AZD9496 with Fulvestrant in Patients with Newly Diagnosed ER+ HER2− Primary Breast Cancer

J.F.R. Robertson, Abigail Evans, Stephan Henschen et al. · Clinical Cancer Research · 2020 · 48 citations · Full text

The alteration of inflammatory markers and apoptosis on chronic prostatitis induced by estrogen and androgen

Yuling Jia, Xu Liu, Jian-yan Yan et al. · International Urology and Nephrology · 2014 · 40 citations

Inflammation, Hormonal Receptor, Immunology +11

Assessing pharmacokinetic differences in Caucasian and East Asian (Japanese, Chinese and Korean) populations driven by CYP2C19 polymorphism using physiologically-based pharmacokinetic modelling

Li Zhou, Pradeep Sharma, Karen Rowland Yeo et al. · European Journal of Pharmaceutical Sciences · 2019 · 40 citations

East Asian, Pharmacokinetic Modeling, Medicine +14

The impact of presence of Hashimoto's thyroiditis on diagnostic accuracy of ultrasound‐guided fine‐needle aspiration biopsy in subcentimeter thyroid nodules: A retrospective study from FUSCC

Lili Gao, Ben Ma, Li Zhou et al. · Cancer Medicine · 2017 · 32 citations · Full text

Safety and Tolerability of a Novel Anti-HER2 Antibody–Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study

Funda Meric‐Bernstam, Emiliano Calvo, Keun Seok Lee et al. · Molecular Cancer Therapeutics · 2023 · 22 citations · Full text